Viewing Study NCT04204057


Ignite Creation Date: 2025-12-24 @ 7:04 PM
Ignite Modification Date: 2025-12-24 @ 7:04 PM
Study NCT ID: NCT04204057
Status: COMPLETED
Last Update Posted: 2024-08-13
First Post: 2019-12-04
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Sponsor:
Organization: